Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
burixafor (GPC-100)
i
Other names:
GPC-100, TG-0054
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
GPCR Therap, TaiGen
Drug class:
CXCR4 antagonist
Related drugs:
‹
GMI-1359 (4)
mavorixafor (3)
POL 6326 (3)
LY2510924 (1)
BMS-936564 (1)
AT 009 (0)
motixafortide (0)
PTX-9908 (0)
CX-01 (0)
plerixafor (0)
GMI-1359 (4)
mavorixafor (3)
POL 6326 (3)
LY2510924 (1)
BMS-936564 (1)
AT 009 (0)
motixafortide (0)
PTX-9908 (0)
CX-01 (0)
plerixafor (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients (NCT01018979)
Phase 2
GPCR Therapeutics, Inc.
GPCR Therapeutics, Inc.
Completed
Phase 2
GPCR Therapeutics, Inc.
Completed
Last update posted :
05/11/2021
Initiation :
02/01/2010
Primary completion :
10/01/2011
Completion :
10/01/2011
CD34
|
burixafor (GPC-100)
PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients (NCT02104427)
Phase 2
GPCR Therapeutics, Inc.
GPCR Therapeutics, Inc.
Completed
Phase 2
GPCR Therapeutics, Inc.
Completed
Last update posted :
04/19/2021
Initiation :
02/01/2015
Primary completion :
11/01/2015
Completion :
11/01/2015
CD34
|
burixafor (GPC-100)
A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease (NCT01458288)
Phase 2
GPCR Therapeutics, Inc.
GPCR Therapeutics, Inc.
Completed
Phase 2
GPCR Therapeutics, Inc.
Completed
Last update posted :
04/19/2021
Initiation :
10/01/2012
Primary completion :
07/01/2013
Completion :
07/01/2013
CD34
|
burixafor (GPC-100)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login